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Background: Patients with uncomplicated acute type B aortic dissection (ABAD) generally can be treated with conser-
vative medical management. However, these patients may develop aortic enlargement during follow-up, with the risk for
rupture, which necessitates intervention. Several predictors have been studied in recent years to identify ABAD patients at
high risk for aortic enlargement who may beneﬁt from early surgical or endovascular intervention. This study system-
atically reviewed and summarized the current available literature on prognostic variables related to aortic enlargement
during follow-up in uncomplicated ABAD patients.
Methods: Studies were included if they reported predictors of aortic growth in uncomplicated ABAD patients. Studies
about type A aortic dissection, aortic aneurysm, intramural hematoma, or ABAD that required acute intervention were
excluded.
Results: A total of 18 full-text articles were selected. The following predictors of aortic growth in ABAD patients were
identiﬁed: age <60 years, white race, Marfan syndrome, high ﬁbrinogen-ﬁbrin degradation product level ($20 mg/mL) at
admission, aortic diameter $40 mm on initial imaging, proximal descending thoracic aorta false lumen (FL) diameter
$22 mm, elliptic formation of the true lumen, patent FL, partially thrombosed FL, saccular formation of the FL, presence
of one entry tear, large entry tear ($10 mm) located in the proximal part of the dissection, FL located at the inner aortic
curvature, fusiform dilated proximal descending aorta, and areas with ulcer-like projections. Tight heart rate control (<60
beats/min), use of calcium-channel blockers, thrombosed FL, two or more entry tears, FL located at the outer aortic
curvature, and circular conﬁguration of the true lumen were associated with negative or limited aortic growth.
Conclusions: Several predictors might be used to identify those ABAD patients at high risk for aortic growth. Although
conservative management remains indicated in uncomplicated ABAD, these patients might beneﬁt from closer follow-up
or early endovascular intervention. (J Vasc Surg 2014;59:1134-43.)Patients with an uncomplicated acute type B aortic
dissection (ABAD) are currently treated conservatively in
the absence of complications such as visceral malperfusion,
renal failure, periaortic hematoma or rupture, or both, re-
fractory pain, or hypertension.1 Despite adequate antihy-
pertensive treatment, delayed aortic dilatation will
develop in 20% to 50% of patients with uncomplicated
ABAD, which can lead to aortic rupture or late-term com-
plications.2-4 In light of this, several randomized controlled
trials studied the importance of prophylactic thoracic endo-
vascular aortic repair (TEVAR) in uncomplicated ABAD.
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4short-term, but very recently, a more positive long-term
outcome after TEVAR has been shown.5,6
Despite this potential beneﬁt, TEVAR may neverthe-
less also be associated with complications, including aortic
rupture, retrograde dissection, and stent graft-related com-
plications such as endoleaks, and therefore, a conservative
approach in many patients is still advocated.7-9 However,
by identifying those patients prone for aortic growth at
an early stage, a subset of patients might be identiﬁed
that can beneﬁt from stricter follow-up and even prophy-
lactic intervention. Especially, a signiﬁcant group of
patients developing widespread aneurysmal degeneration
along the dissected segments during follow-up may lose
the chance for endovascular treatment if not identiﬁed at
an early stage. In this report we systematically reviewed
the current literature for the different predictors of aortic
growth in conservatively treated uncomplicated ABAD
patients.
METHODS
Literature search. An electronic literature search was
performed in the MEDLINE and EMBASE databases for
original manuscripts published until August 7, 2013. The
language was restricted to English, and key search terms
were “uncomplicated type B aortic dissection,” “predic-
tors,” and “growth” and corresponding synonyms. The
Fig 1. Flow chart.
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dissection or type B aortic dissection and predict* or prog-
nos* and growth or diameter. A similar search was used for
the EMBASE database.
Selection of publications. After removal of duplicates,
two reviewers (G.B., J.T.) independently screened titles
and abstracts of the remaining articles. Manuscripts were
included if predictors of aortic growth in conservatively
treated uncomplicated ABAD were studied. Articles about
type A aortic dissection, aortic aneurysm, or about invasive
treatment in the acute phase were excluded. Full-text ver-
sions of studies that matched the inclusion criteria were
obtained. The reference lists of the included articles were
screened, and relevant publications not identiﬁed in the
primary electronic search were included through cross-
referencing. All full-text articles were studied by two in-
dependent physicians, and in case of disagreement,
consensus was reached during a consensus meeting.
Data analysis. The Meta-analysis of Observational
Studies in Epidemiology (MOOSE) guidelines were used
for analysis of the different studies in this systematic review.
These guidelines provide a checklist to examine meta-
analyses of observational studies to aid authors, reviewers,
readers, and editors.10 Included studies were critically
assessed for study quality, heterogeneity, bias, and limita-
tions. The following data were extracted from the included
studies: study population, patient characteristics, follow-up
time, aortic enlargement, other aortic events, and pre-
dictors of aortic growth.Statistical analyses of the studies were limited to calcu-
lating sex and the mean or median values of age, follow-up
time, and aortic growth rates. Data pooling by univariate to
multivariate regression analysis was not feasible because
original data were generally not available or because most
studies used multiple variables and end points varied
among the included studies. Therefore, this study provides
an overview of the available predictors of aortic growth for
uncomplicated ABAD patients.
RESULTS
The literature search resulted in 18 relevant studies that
were included for this review (Fig 1).11-28 The different
studies analyzed 1692 ABAD patients (70% male), with a
mean age of 64 6 12 years and a median follow-up of
51.6 months (range, 23.2-59.0 months). It should be
noted that different studies may have used a (partial) similar
population in different publications and as a result the total
number of patient might be overestimated.18,19,23-26
Study characteristics of the included studies are pre-
sented in Table I. There was clinical, methodologic, and
statistical diversity among the included studies; however,
16 studies (89%) were retrospective, 12 (67%) were per-
formed in a single institution, and in 15 studies (83%),
predictors were analyzed using multivariate regression anal-
ysis (Table I). One study used the International Registry of
Acute Aortic Dissection (IRAD).13 The mean aortic
growth rate at the descending thoracic aorta in the
included studies was 2.6 mm/y (range, 0.4-4.1 mm/y).
Table I. Study characteristics
First author (year)
Patients
included
Follow-up in months
Aortic event
Growth rate in mm/y,
Median (IQR) or mean 6 SD (range) mean 6 SD
Kato (1995)14 41 38.4 (4-140) 15/41 (36.6%) aortic
enlargement
Mean growth rate: 0.4
(range, 0.3 to 20)
Marui (1999)18 101 59 (2-125) 43/101 (42.6%) aortic
enlargement
NA
Onitsuka (2004)21 76 52.4 6 35.9 (3.1-120.7) 22/76 (28.9%) aortic
enlargement
Event group: 5.3 6 3.1
Nonevent group: 0.1 6 2.0
Akutsu (2004)11 110 59.0 12/110 (10.9%) aortic rupture
17/48 (35.4%) surgery in
patent group
3/62 (4.8%) surgery in
thrombosed group
NA
Sueyoshi (2004)23 62 49.1 6 48.7 (2-192) 52/62 (83.9%) aortic
enlargement ($1 segments
increased during follow-up)
Blood ﬂow in FL: 3.3 6 4.2
No blood ﬂow in FL: 1.4 6 8.6
Thoracic aorta: 4.1 6 6.5
Dissection abdominal aorta:
1.2 6 5.9
Winnerkvist
(2006)28
66: 26 IMH, 40
ABAD treated
medically
79 (22-179) 11/40 (27.5%) aortic event NA
Kunishige (2006)17 131 51.6 (0-199) NA NA
Marui (2007)19 141 64.4 (1-157) 59/141 (41.8%) aortic events NA
Song (2007)22 100
(51 AAAD;
49 ABAD)
53 6 26 (total population
AAAD + ABAD)
12/49 (24.5%)
Aortic enlargement
Upper descending thoracic
aorta: 3.05 6 3.12
Mid descending thoracic aorta:
2.87 6 2.53
Lower descending thoracic
aorta: 2.45 6 1.61
Abdominal aorta: 1.28 6 1.92
Kitada (2008)15 78 12
All patients 12 months follow-up
Late aortic events at 1 year:
9/78 (11.5%) patients
NA
Kodama (2008)16 171 27 (6.9-57) 39/171 (22.8%)
Pathological aortic expansion
> 5 mm/year
8/171 (4.7%) Aortic rupture
NA
Sueyoshi (2009)24 71 48.9 6 49.4 (6-120) 52/210 (72.4%)
Segments with aortic
enlargement
58/210 (27.6%)
Segments no change or
decrease in size
Completely closed FL: 0.26 0.6
Partially closed FL: 4.0 6 4.3
Patent FL: 4.9 6 4.5
AAAD, Acute type A aortic dissection; ABAD, acute type B aortic dissection; BPM, beats per minute; FI, fusiform index; FL, false lumen; IMH, intramural
hematoma; IQ, interquartile range; LSA, left subclavian artery; NA, not available; SD, standard deviation; TL, true lumen; ULP, ulcer-like projections.
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Table I. Continued.
Predictors Negative predictors
Individual study quality (1), type of study (2),
institution (3), and analysis (4)
d Diameter $40 mm at initial imaging
d Patent primary entry site in the thorax
NA 1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Diameter $40 mm at initial imaging
d Patent FL
d Diameter <40 mm at initial imaging
d Thrombosed FL
1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Patent FL
d Maximum aortic diameter >40 mm at
onset
d Thrombosed FL 1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Patent FL
d In patients with patent FL: location of the
most dilated aortic segment at the distal
arch
d Thrombosed FL 1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Presence of blood ﬂow in the FL NA 1. Good
2. Retrospective
3. Multi-institution (n ¼ 2)
4. Multivariate
d Areas with localized dissection/ULP
d Max aortic diameter >40 mm at onset
NA 1. Good
2. Prospective
3. Single institution
4. Multivariate analysis
d Patent FL
d Diameter $45 mm at initial imaging
d Thrombosed FL
d Diameter <45 mm at initial imaging
1. Fair
2. Retrospective
3. Single institution
4. Multivariate analysis
d Degree of fusiform dilatation of the prox-
imal descending aorta (FI $0.64)
d Patent FL
d Large aortic diameter >40 mm
d FI <0.64
d Thrombosed FL
d Diameter <40 mm
1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Proximal descending thoracic aorta FL
diameter ($ 22 mm) on initial imaging
d Marfan’s syndrome
d Large aortic diameter at the mid descend-
ing thoracic aorta
NA 1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d Fibrinogen-ﬁbrin degradation product
level $ 20 microg/ml on admission
NA 1. Fair
2. Retrospective
3. Single institution
4. Multivariate analysis
d Heart rate > 60 BPM d Heart rate # 60 BPM 1. Good
2. Retrospective
3. Single institution
4. Univariate analysis
d Saccular formation in partially
closed FL
NA 1. Good
2. Retrospective
3. Multi-institution (n¼2)
4. Multivariate analysis
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Table I. Continued.
First author (year)
Patients
included
Follow-up in months
Aortic event
Growth rate in mm/y,
Median (IQR) or mean 6 SD (range) mean 6 SD
Miyahara (2011)20 160 33.5 6 20.5 (2.0-88.0) 32/160 Late aortic events Thrombosed: 0.2 6 2.8
Thrombosed with ULP: 4.8 6 10.9
Patent group: 5.3 6 5.9
Evangelista
(2012)12
184 (108 AAAD
surgically treated,
76 ABAD treated
medically)
77 (6-204)
AAAD + ABAD
52/76 (68.4%) Aortic events Median (Q1-Q3)
Entry tear $ 10 mm: 0.8 (0.2-1.9)
Entry tear < 10 mm: 0.2 (0.1-0.5)
Jonker (2012)13 191 24 (1-2 years) 113/191 (59%) Aortic
expansion
Mean growth rate: 1.7 6 7.6
White race: 2.6; No white race: -3.1
Diameter < 40 mm: 3.8; Diameter
$ 40 mm: 0.2
Women: -0.3; Men: 2.6; IMH: -0.6;
No IMH: 3.1; Calcium-channel
blockers: 0.5; No calcium-channel
blockers: 3.9
Trimarchi (2013)27 84 19.5 (1-149.5) Aortic enlargement
102/125 (81.6%) Patent FL;
98/125 (78.4%) Partial FL
thrombosis; 15/23 (65.2%)
Complete thrombosis
Mean growth rate: 3.0 6 8.1
Partial thrombosis FL: 4.3 6 10.2
Patent FL: 2.1 6 5.6
Completely thrombosed FL: 1.56 5.6
Tolenaar (2013)26 60 23.2 (3-132) NA 1 entry tear: 5.6 6 8.9
2 entry tears: 2.1 6 1.7
3 entry tears: 2.2 6 4.1
Tolenaar (2013)25 62 22.3 6 28.2 (3-132) 211/248 (85.1%) Segments
with aortic growth.
37/248 (14.9%)
Segments with stable or
reduced aortic growth.
Mean growth rate: 3.1 6 6.3
Age < 60 years: 4.2 6 7.5
Age $ 60 years: 1.8 6 4.1
Saccular formation: 7.8 6 13.6
Nonsaccular formation: 3.0 6 5.0
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growth were age <60 years, white race, Marfan syndrome,
and a ﬁbrinogen-ﬁbrin degradation product (FDP) level of
$20 mg/mL at admission.12,13,15,23,25 Increasing age
($60 years), tight heart rate control (<60 beats/min),
and the use of calcium-channel blockers were associated
with less aortic growth.13,16,23,25
Morphologic predictors at initial imaging for aortic
growth were aortic diameter $40 mm, proximal descend-
ing thoracic aortic false lumen (FL) diameter $22 mm,
elliptic conﬁguration of the true lumen (TL), patent FL,
partially thrombosed FL, saccular formation of FL, one en-
try tear, large ($10 mm) entry tear located in the proximal
part of the dissection, FL located at the inner aortic curva-
ture, fusiform index $0.64, and areas with ulcer-like pro-
jections (ULPs).1,11,12,14,17-24,26-28 A maximum aortic
diameter of <40 mm, thrombosed FL, a circular conﬁgura-
tion of the TL, intramural hematoma, increased number of
entry tears (two or more), and FL located at the outeraortic curvature were associated with decreased aortic
growth.13,17,19,25,26 The positive and negative predictors
of aortic growth in uncomplicated ABAD are summarized
in Table II.
DISCUSSION
The present review is the largest study yet to assemble
the best available evidence of the group of patients at risk
for aortic growth among medically treated uncomplicated
ABAD patients. The current available literature reports a
combination of clinical and radiologic predictors that
might be useful for selecting those patients who might
beneﬁt from close radiologic surveillance or early
intervention.
Clinical predictors. In agreement with earlier ﬁnd-
ings, the ABAD patients included in these studies were
more commonly men (70%) with a mean age of 64 years.29
Age is an important risk factor, because age <60 years was
associated with signiﬁcantly increased aortic growth rate,
Predictors Negative predictors
Individual study quality (1), type of study (2),
institution (3), and analysis (4)
d Thrombosed FL with ulcer-like
projections
d Patent FL
d Patient age (younger age, more
events)
d Maximum aortic diameter $ 40 mm
at onset
d Patient age (older age, less events) 1. Fair
2. Retrospective
3. Single institution
4. Univariate analysis
d Marfan
d Maximum aortic diameter
d Patent FL
d Large entry tear located in the proximal
part of the dissection
NA 1. Good
2. Retrospective
3. Single institution
4. Multivariate analysis
d White race
d Small initial aortic diameter
d Women
d IMH
d Use of Calcium-channel blockers
1. Good
2. Prospective observational
3. Multi-institution (n ¼ 28)
4. Multivariate analysis
d Partially thrombosed FL NA 1. Good
2. Retrospective
3. Multi-institution (n ¼ 4)
4. Multivariate analysis
d One entry tear d Increased number of entry tears
($ 2)
1. Good
2. Retrospective
3. Multi-institution (n ¼ 4)
4. Univariate analysis
d Age < 60 years
d Male gender
d Saccular formation of the partially
thrombosed FL
d FL located at the inner aortic
curvature
d An elliptic conﬁguration of the TL
d Increasing age
d FL located at the outer aortic curvature
d A circular conﬁguration of the TL
1. Good
2. Retrospective
3. Multi-institution (n ¼ 4)
4. Multivariate analysis
Table I. Continued.
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growth rate.23,25 As the aortic wall becomes more rigid
during life due to degeneration and the presence of
atherosclerotic factors, it becomes less prone to dilate. In
addition, aortic dissection in younger individuals identiﬁes
a cohort with a higher chance of genetic abnormalities that
contribute to degradation of aortic elastic elements over
time.18
Some discrepancies have been reported about the role
of gender in favoring aortic growth in ABAD patients.
Recent reports showed that men experienced a higher
growth rate than women,13,25 whereas aortic growth was
previously reported as higher in women.23 The controversy
between such observations remains unresolved.
However, our study further supports the association of
connective tissue disorders, primarily Marfan syndrome,
and a higher rate of aortic events during follow-up. Marfan
syndrome is a clinical predictor for aortic enlargement and
related death.12,30 Furthermore, racial differences wereexamined. White race was associated with aortic expansion,
which was less frequently seen in Asian patients.13 These
racial disparities are supported by a signiﬁcantly lower prev-
alence of abdominal aortic aneurysm in the Asian popula-
tion compared with the white population.31,32
During follow-up, patients with appropriate blood
pressure control (systolic blood pressure <120 mmHg)
and a tight control of heart rate of <60 beats/min had a
better outcome with less aortic events, including aortic
expansion and rupture, compared with patients with a heart
rate $60 beats/min and appropriate blood pressure con-
trol.16 These ﬁndings emphasize the importance of
adequate blood pressure and heart rate control, not only
in the acute phase but also during follow-up, and therefore,
careful treatment and strict follow-up is required in all
ABAD patients.
Beside b-blockers for control of heart rate and blood
pressure, calcium channel antagonists may also be indicated
for blood pressure control, because the IRAD data
Table II. Summary of the predictors of aortic growth in uncomplicated type B aortic dissection
Variable Predictor Negative predictor
Patient characteristics Age <60 years Increasing age ($60 years)
White race
Heart rate $60 beats/min Heart rate <60 beats/min
Medical history Marfan syndrome
Clinical information Use of calcium-channel blockers
Blood test FDP level $20 mg/mL on admission
Radiologic signs Aortic diameter $40 mm during acute phase Diameter <40 mm (debated)
Patent FL Closed/thrombosed FL
Partially thrombosed FL (debated)
Proximal descending thoracic aorta FL diameter ($22 mm) on initial
imaging
Intramural hematoma
Sac formation in partially thrombosed FL
One entry tear Increased number of entry tears
FL/intimal tear located at the inner aortic curvature FL/intimal tear located at the
outer curvature
An elliptic conﬁguration of the TL/round conﬁguration FL A circular conﬁguration of the
TL/elliptic conﬁguration FL
Areas with localized dissection/ULP
Degree of fusiform dilatation of the proximal descending aorta (FI $0.64) FI <0.64
Large entry tear ($10 mm) located in the proximal part of the dissection
FDP, Fibrinogen-ﬁbrin degradation product; FI, fusiform index; FL, false lumen; TL, true lumen; ULP, ulcer-like projection.
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exhibit less aortic growth.13 These observational data are
supported by several clinical trials underlining the beneﬁcial
effect of calcium channel blockers in hypertension con-
trol.33,34 Although such observations need to be conﬁrmed,
the association of these antihypertensive drugsmight be use-
ful for treating ABAD in the long-term.
At admission, certain blood tests might also have
predictive value. Kitada et al15 showed that FDP level
$20 mg/mL at admission was associated with aortic
growth, where other laboratory factors, such as thrombin-
antithrombin III complex, D-dimer, platelet count and
co-reactive protein were not associated with aortic
enlargement.15 It should be noted that the follow-up in-
terval was only for 1 year, and long-term follow-up of
these markers remains undeﬁned. Although FDP has
not been introduced as a routine screening tool, blood
tests for such biomarkers, in association with other
predictors, might be useful for detecting those ABAD
patients at higher risk for aortic growth at an early stage.
Future research should investigate if the different
biomarkers for thoracic aortic aneurysm may also be
predictive for aortic growth in uncomplicated ABAD
patients.35
Radiologic predictors. Most of the studies that were
analyzed focused on morphologic predictors at the initial
aortic imaging stage. In several reports, a maximum aortic
diameter of $40 mm in the acute phase was marked as a
predictor of aortic growth, whereas a diameter
of <40 mm was a negative predictor.14,17-19,21,28 Most
studies deﬁne aortic enlargement as a maximum diameter
of the dissected aorta of $60 mm or rapid enlargement of
$10 mm/y, or both, because this dictates surgical inter-
vention. These ﬁndings are related to the fact that patientswith a higher initial maximum diameter will generally reach
the boundary of 60 mm earlier than patients with a smaller
diameter and show higher growth rates.14,18,23
In contrast to these ﬁndings, the IRAD data showed
that an initial diameter of <40 mm was predictive for aortic
expansion during follow-up.13 These ﬁndings suggest that,
besides patients with a high initial aortic diameter, patients
with a lower initial aortic diameter may also present with an
important aortic growth and therefore should be moni-
tored more closely than previously assumed. Again, in
this particular group of patients, a potential explanation
would be a higher genetic inﬂuence in patients with aortic
dissection at a small size. However, a selection bias might
have affected the results: large dissected aortas were
excluded for analysis because they generally more often un-
dergo early intervention.13
Looking more in detail at the diameter of the descend-
ing thoracic aorta in ABAD patients, a distinction between
the total aortic diameter and the FL diameter can be
made. Song et al22 found that a FL diameter of $22 mm
in the upper thoracic descending aorta on the initial
computed tomography imaging was an independent predic-
tor for aortic enlargement during follow-up. In patients who
showed aortic growth during follow-up, the initial FL diam-
eter correlated with the rate of aortic dilatation at the prox-
imal descending aorta. Furthermore, the ratio of FL
diameter to total aortic diameter increased at the proximal
and middle descending thoracic aorta in these patients.22
A large FL diameter reﬂects high pressure in the FL, and
consequently, may play an essential role in aortic dilatation
of the FL and development of thoracic aortic aneurysm.
In addition, the conﬁguration of the FL reﬂects the
pressure inside it. An elliptical conﬁguration of the TL in
combination with a circular formation of the FL was
Fig 2. Computed tomography images show the conﬁguration of true lumen (TL) and false lumen (FL). A, A circular-
shaped TL is shown. B, An elliptic shape results when the FL compresses the TL. Adapted from Tolenaar et al with
permission of Elsevier.25
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This conﬁguration is the result of higher pressurization of
the FL, which effects the shape of the TL, subjects the
FL to higher radial forces, and leads to a potential aortic
enlargement.25 Similarly, a circular TL conﬁguration sug-
gests a high pressure in the TL compared with the FL,
and this radiologic sign was associated with a decreased
growth rate (Fig 2).25
Several studies have described the presence of blood
ﬂow in the FL as a predictor of aortic growth.11,17-19,21,23
A patent FL causes direct hemodynamic stress and structural
weakening of the aortic wall, which might induce progres-
sive growth of the affected aortic segment, whereas a
completely thrombosed FL has been associated with less
aortic enlargement and even aortic wall remodeling.17,18,24
However, it has been reported that patients with a throm-
bosed FL, but presenting with a penetrating atherosclerotic
ulcer (PAU), are prone for aortic events.20,28 PAUs have
been thought to develop into (saccular) aneurysms, and
this may explain the signiﬁcant relationship between
thrombosed FL with ULPs and aortic events.20 ULPs are
described as projections of the site of the intimal tear, the
site of the occlusion, or the detachment of origins of side
branches and PAUs. However, the deﬁnition of ULPs still
remains indistinct and needs to be further clariﬁed in future
research.20,36
In patients with a patent FL, mortality and the need
for surgical or endovascular treatment both increased
from the third year of follow-up, which implicates that
structural and dynamic changes in the aortic wall and
aorta require time to appear.12 Hemodynamics in the pat-
ent FL are probably too complex to be predicted with pre-
operative morphologic features, and further in vitro
studies and dynamic magnetic resonance imaging in the
acute phase should be developed to understand this
complex.
Even more debated is the importance of a partially
thrombosed FL, since an IRAD report documented theassociation between partial FL lumen thrombosis and
lower survival at 3 years during follow-up in ABAD pa-
tients.30 Other groups24 did not ﬁnd a relation between
partially thrombosed FL and aortic enlargement, whereas
more recent studies did show partial lumen thrombosis
was predictive for aortic growth.25,27 In contrast, Sueyoshi
et al24 observed that patients with a saccular formation of
the FL, which is deﬁned as partial thrombosis in the distal
portion of the FL with proximal ﬁlling of the FL, forming a
blind sac, demonstrated a signiﬁcantly higher growth rate
compared with no sac formation.24 These ﬁndings were
conﬁrmed by another more recent study.25 A higher dia-
stolic FL pressure due to occlusion of distal re-entry tears
may be the origin of the aortic enlargement. These ﬁndings
are in line with previous reports that a patent primary entry
site in the thorax was predictive for aortic enlargement
compared with an absent primary entry site.14
Recently, Tolenaar et al26 found that the number of
entry tears at initial imaging was associated with aortic
growth during follow-up. Patients with one entry tear at
presentation show a higher growth rate than patients
with more entry tears.26 The presence of only one patent
entry tear might pressurize the FL and change, in this
latter, the normal laminar ﬂow into turbulent ﬂow, leading
to higher stress of the aortic wall and, subsequently, in
combination with a weakened dissected aortic wall, to
aortic enlargement.37 In addition, Evangelista et al12
demonstrated that patients with a primary entry tear
$10 mm presented more often with dissection-related
events and had a higher growth rate than those with an en-
try tear <10 mm. A bigger tear size suggests that more
blood enters the FL, leading to higher FL pressurization
and, subsequently, aortic enlargement.
In vitro studies demonstrated that a large tear size pre-
sents with lower velocity through the tears but more com-
plex ﬂows in the FL, whereas small tears resulted in lower
FL pressure, with higher tear velocities, and a well-deﬁned
ﬂow.38 FL hemodynamics are dependent from cumulative
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in the management of type B aortic dissection patients.38
Another in vitro study showed that systolic pressure in
the FL decreases with tear size, and similarly, higher FL
pressure with greater tear size will increase wall shear stress
and may cause aortic dilatation.39
Different radiologic predictors, including patent FL,
FL diameter $22 mm, elliptic TL combined with round
FL, one entry tear, and entry tear size $10 mm all seem
inter-related due to pressurization of the FL, with subse-
quent aortic growth of the dissected segment. A FL located
in the inner curvature of the aorta was associated with
aortic enlargement in a study that was in concordance
with another experience that showed that a primary entry
tear in the inner curvature/concavity was associated with
the development of complications.25,40 Although there is
no consensus yet, congruently with these ﬁndings, a FL
located at the inner aortic curvature seems associated
with a higher incidence of aortic complications in clinical
practice, both in the acute and chronic setting.
Another radiologic predictor was reported by Marui
et al,19 who used the shape of the proximal descending
aorta as a possible predictor of aortic growth, expressed
in the fusiform index. The fusiform index was deﬁned as
A/(B þ C), with A indicating the maximum diameter of
the proximal descending aorta, B indicating the diameter
of the distal aortic arch, and C indicating the diameter of
the descending aorta at the level of the main pulmonary ar-
tery.19 A fusiform index of$0.64 is an independent predic-
tor for aortic events. In a fusiform-shaped aorta, the aortic
wall at the outer curvature of the dissected aortic wall may
be fragile, and the ﬂow pattern changed, which can both
lead to aortic dilatation.19
Combining these clinical and radiologic predictors may
be essential to identify patients with uncomplicated ABAD
at higher risk for aortic enlargement and rupture during
follow-up.
This study has some limitations. This review provides an
extensive overview of the different published predictors for
aortic growth in uncomplicated ABAD patients. However,
an important limitation of this review is that data pooling
was not possible because the original data for most of the
studies were not available and different end points were
used. Additionally, an important part of the included studies
mainly evaluated Asian patients. Although studies from
different continents often showed similar predictors for
aortic growth, the results may not be completely generaliz-
able for the European and American population due to
important differences in genetics and lifestyle. Future
research should be focused on additional biomarkers and
further applicability of dynamic imaging and computational
analysis into clinical practice.
CONCLUSIONS
Several predictors might be used to identify those
ABAD patients at high risk for aortic growth during
follow-up. Although conservative management remains
indicated in all uncomplicated ABAD, in particular duringthe acute phase, these patients might beneﬁt from closer
radiologic surveillance or early endovascular intervention.
This approach deserves even more consideration because
a signiﬁcant group of patients develops aneurysmal degen-
eration along the dissected segments during follow-up and
may lose the chance for endovascular treatment if not iden-
tiﬁed at an early stage.AUTHOR CONTRIBUTIONS
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